Market Wire - Pharmaceuticals and Biotech
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
13630 records returned
GLG Life Tech Corporation: GLG Life Tech Corporation Commences Trading on NASDAQ
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) GLG Life Tech Corporation (TSX: GLG)(NASDAQ: GLGL) ("GLG" or the "Company"), the vertically integrated leader in the agricultural and industrial development of high quality stevia extracts, announced today that it has commenced trading on the NASDAQ Global Market under the symbol "GLGL". GLG's common shares are dual listed on the Toronto Stock Exchange and the NASDAQ Global Market. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech GLG GLGL Source Type: news
ProMetic Life Sciences Inc.: SaBTO Recommends Use of P-Capt(R) Prion Reduction Filter to Protect Children From vCJD Blood TransmissionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MONTREAL, QUEBEC, CANADA and LILLE, FRANCE (MARKET WIRE) ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") and MacoPharma SA ("MacoPharma") announce that the Advisory Committee on the Safety of Blood, Tissues and Organs ("SaBTO"), an independent Committee that advises the UK Department of Health ("DoH"), has recommended the adoption of the P-Capt(R) prion reduction filter to pre-treat red blood cells destined for children born since 1 January 1996. The filter, which 'cleans' blood prior to use, removes the prion responsible for variant Creutzfeldt-Jakob disease ("vCJD"). The Committee also indicated that the requirement ...
Source: Market Wire - Pharmaceuticals and Biotech - November 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech PLI Source Type: news
Unilife Medical Solutions: Unilife Appoints Unifill(TM) Automated Assembly Line SupplierEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LEWISBERRY, PA (MARKET WIRE) Unilife Medical Solutions Limited ("Unilife" or "the Company") (ASX: UNI)(PINKSHEETS: UNIFF) today announced the appointment of Mikron Group ("Mikron") as its contracted supply partner for the development and supply of automated assembly systems to support the commercial production of the Unifill(TM) ready-to-fill syringe (Unifill(TM) syringe). (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 19, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Manufacturing and Production UNI UNIFF Source Type: news
ThermaFreeze Products Corporation: ThermaFreeze Announces Formation of Majority-Owned Subsidiary American Diversified Medical CorporationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MOBILE, AL (MARKET WIRE) ThermaFreeze Products Corporation (PINKSHEETS: TZPC), the maker of patented, innovative refrigerant products designed for use in the commercial shipment of perishables and for use as a consumer compress and chiller product, today announced the formation of a majority-owned subsidiary named American Diversified Medical Corporation (ADM), which will offer products and services to the alternate site healthcare space, specifically homecare and clinics outside of the hospital environment and veterinarian market. ThermaFreeze and ADM plan to announce a portfolio of new therapeutic products called (Source...
Source: Market Wire - Pharmaceuticals and Biotech - November 18, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Food and Beverage Retail Manufacturing and Production TZPC Source Type: news
S3 Investment Company: S3 Investment Company Comments on Status of Quarterly Financial ReportEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DANVILLE, CA (MARKET WIRE) S3 Investment Company, Inc. (PINKSHEETS: SIVC) today commented on the status of its consolidated financial report for the period ended September 30, 2009, which were scheduled to be posted to the Pink Sheets OTC Disclosure and News Service this week. Due to the turnover in the company's accounting personnel, the quarterly financials will be delayed approximately 30 days and are expected to be filed by December 15, 2009. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 18, 2009 Category: Pharmaceuticals Tags: Financial Services Pharmaceuticals and Biotech Medical and Healthcare Manufacturing and Production SIVC Source Type: news
Cleveland BioLabs, Inc.: Cleveland BioLabs Publishes New Insights Into Mechanism of Action of Curaxins, Extending Their Clinical PotentialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BUFFALO, NY (MARKET WIRE) Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that a breakthrough discovery into the mechanism of action of the Company's first generation Curaxin anticancer compounds was published in an international health science journal, Cell Cycle (Neznanov et al., Cell Cycle 8:23, 1-11; December 1, 2009). (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 18, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech CBLI Source Type: news
Allon Therapeutics Inc.: Allon Chosen as "Top 10 Partnering Candidate" and Presenting at Major Partnership ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) Allon Therapeutics Inc. (TSX: NPC) announced today its lead drug candidate, davunetide, has been selected as one of the Top 10 partnership candidates by a leading industry expert. The 2009 Windhover Therapeutic Areas Partnership Conference features the Top 10 candidates. Bruce Morimoto, Vice-President of Drug Development at Allon, will present an overview of the davunetide program at the conference in Boston, MA on November 18. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 17, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech NPC Source Type: news
Xigen: Xigen Announces $20 Million Series B Financing and Clinical Safety Data for Lead Product XG-102Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LAUSANNE, SWITZERLAND (MARKET WIRE) Xigen, a Swiss biopharmaceutical company developing innovative cell-penetrating peptides with high stability and specificity for a broad range of therapeutic indications, announced today the completion earlier this year of a Series B financing round in which it raised USD 20 million (CHF 20 million) from existing investor Tilocor Life Science. This round of financing allowed Xigen to successfully complete a first-in-human Phase I study of its lead peptide drug candidate XG-102 administered intravenously. The funds will also enable the company to further clinical development of XG-102 in ...
Source: Market Wire - Pharmaceuticals and Biotech - November 16, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Source Type: news
BioPharm Insight: BioPharm Insight and i3 Pharma Informatics Announce Clinical Information AllianceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NORWOOD, MA (MARKET WIRE) BioPharm Insight(TM), a division of Pearson PLC (NYSE: PSO), and i3 Pharma Informatics today announced an alliance that will bring healthcare claims information to clinical operations professionals, assisting in patient enrollment, physician and site selection, and feasibility analysis. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 16, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Computers and Software Medical and Healthcare PSO Source Type: news
OR-Live, Inc.: REMINDER: This Week on ORLive (November 11, 2009): Seven New Live Programs Featuring a Trauma and Critical Care Symposium, Live Orthopaedic Surgeries, a Live Demonstration of Synthetic Sealant for European Audiences, and a Special Parent Focused Interactive Discussion on H1N1 and ChildrenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WEST HARTFORD, CT (MARKET WIRE) ORLive, your destination for live and on-demand surgery video, will present seven new live broadcasts this week. The broadcast week will launch with a live two-day symposium for trauma and critical care from Massachusetts General Hospital, and three live orthopaedic surgeries. Also on Tuesday we'll present a European audience focused broadcast on Synthetic Sealants used in lung surgery, and wrap up the week with two interactive parent focused broadcasts from Akron Children's Hospital, including a special H1N1 focused discussion. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 16, 2009 Category: Pharmaceuticals Tags: Education and Training Pharmaceuticals and Biotech Medical and Healthcare Media and Entertainment Source Type: news
EnWave Corporation: EnWave Signs Letter of Intent to Sell nutraREV(R) Food Dehydration Technology in South and Central AmericaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) EnWave Corporation (TSX VENTURE: ENW)(FRANKFURT: E4U) ("EnWave" or "the Company"), has signed a Letter of Intent ("LOI") with a North American consortium for the purpose of selling up to four commercial-scale nutraREV(R) food dehydration machines over the next four years. The machines will be used for the production of a variety of dried fruit and vegetable products grown in South and Central America. SmartPac, LLC of California, and Innovative Food Systems ("IFS") of Princeton, British Columbia (together, "the Consortium"), intend to establish the first nutraREV(R) plant in Centra...
Source: Market Wire - Pharmaceuticals and Biotech - November 12, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare ENW E4U Source Type: news
Ondine Biopharma Corporation: Ondine Biopharma Announces Third Quarter 2009 Financial ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) Ondine Biopharma Corporation (the "Company" or "Ondine") (TSX: OBP)(AIM: OBP) a medical device company developing photodisinfection based products, today announced its financial results for the third quarter ended September 30, 2009. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 12, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech OBP Source Type: news
BioElectronics Corporation: BioElectronics to Announce Results of Acetaminophen Comparison StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FREDERICK, MD (MARKET WIRE) BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced that results from the recently completed acetaminophen comparison study will be released on Monday, November 16th after the close of the market. The study compares the effects of ActiPatch(R) Therapy to acetaminophen in the form of Extra Strength Tylenol(R) for the treatment of Delayed Onset Muscle Soreness (DOMS). (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 11, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech BIEL Source Type: news
myMatrixx: myMatrixx Renews Contract With Steven P. Stanos, Jr., DOEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TAMPA, FL (MARKET WIRE) myMatrixx(TM) today announced the extended appointment of Steven P. Stanos, Jr., DO, as Medical Director. Dr. Stanos is nationally recognized for his significant contributions to the fields of pain management and rehabilitation. This appointment represents the continued steps that myMatrixx is taking to not only position itself as the leader in technology driven efficiencies, but also position the company as a leader in clinical programs, specifically pain management outcomes. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 11, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
Unilife Medical Solutions: Unilife Announces Appointment of New Independent DirectorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LEWISBERRY, PA (MARKET WIRE) As announced on 1 September 2009, Unilife Medical Solutions Limited ("Unilife" or "the Company") (ASX: UNI) (PINKSHEETS: UNIFF) is currently undertaking a transaction to redomicile the Unilife group in the United States of America ("US") and is also seeking to list on NASDAQ. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 11, 2009 Category: Pharmaceuticals Tags: Financial Services Pharmaceuticals and Biotech Medical and Healthcare UNI UNIFF Source Type: news
Kelly Scientific Resources: Third Annual Salary Survey Reveals High Employee Morale in the WestEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TROY, MI (MARKET WIRE) According to findings from Lab Manager Magazine's third annual salary survey, employee morale has generally remained high in the West despite the state of the current economy. This is the first year that Kelly Scientific Resources, a specialty service of Kelly Services, Inc. (NASDAQ: KELYA) (NASDAQ: KELYB), has sponsored the survey with Lab Manager Magazine. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 10, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech KELYA KELYB Source Type: news
Kelly Scientific Resources: Third Annual Salary Survey Reveals High Employee Morale in the SoutheastEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TROY, MI (MARKET WIRE) According to findings from Lab Manager Magazine's third annual salary survey, employee morale has generally remained high in the Southeast despite the state of the current economy. This is the first year that Kelly Scientific Resources, a specialty service of Kelly Services, Inc. (NASDAQ: KELYA) (NASDAQ: KELYB), has sponsored the survey with Lab Manager Magazine. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 10, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech KELYA KELYB Source Type: news
Kelly Scientific Resources: Third Annual Salary Survey Reveals High Employee Morale in the MidwestEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TROY, MI (MARKET WIRE) According to findings from Lab Manager Magazine's third annual salary survey, employee morale has generally remained high in the Midwest despite the state of the current economy. This is the first year that Kelly Scientific Resources, a specialty service of Kelly Services (NASDAQ: KELYA) (NASDAQ: KELYB), has sponsored the survey with Lab Manager Magazine. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 10, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech KELYA KELYB Source Type: news
Global Health Ventures Inc.: Global Health Ventures Receives the First Shipment of Its Commercially Manufactured Male Enhancement Drug "X-Excite"Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) Global Health Ventures Inc. (OTCBB: GHLV), or the "Company" a Specialty Pharma is pleased to announce today that it has completed the prototype manufacturing of the drug "X-Excite" Global's male enhancement drug. The manufacturing of the product was carried out under contract with Vida Pharma of Montreal, Canada. Vida Pharma specialized in the designing of the new tablet size, taste, and hardness. The Company has manufactured over 4000 pills from several different incipient and coatings that are all safe for human consumption. These various batches will be tested at the University ...
Source: Market Wire - Pharmaceuticals and Biotech - November 9, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare GHLV Source Type: news
Stellar Pharmaceuticals Inc.: Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued ProfitabilityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LONDON, ONTARIO (MARKET WIRE) Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced its financial results for the third quarter ended September 30, 2009. In this press release, unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been rounded to nearest hundred. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 6, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare SLXCF Source Type: news
NanoLogix Inc.: NanoLogix Files International Patent Applications, Reclaims 18 Existing Patents, Noted in Department of Defense Quarterly Publication and Provides Operations UpdateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HUBBARD, OH (MARKET WIRE) NanoLogix, Inc. (PINKSHEETS: NNLX) announces that the company has recently filed BNP™ (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU. These applications were filed in order to obtain intellectual property protection for the company's technology in countries viewed as representing the largest potential international market for BNP rapid detection, a revolutionary sandwiched-membrane Petri-based technology that can reduce microorganism detection times by 100-400%. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare NNLX Source Type: news
Ambrilia Biopharma Inc.: Ambrilia Biopharma Provides Bi-Weekly Status UpdateEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MONTREAL, QUEBEC (MARKET WIRE) Ambrilia Biopharma Inc. (TSX: AMB) is providing today its bi-weekly Default Status Report under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("Default Status Report"). (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech AMB Source Type: news
Cutting Edge Information: Pharmaceutical Speaker Programs an Important Source of Medical Education, Says Cutting Edge InformationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RESEARCH TRIANGLE PARK, NC (MARKET WIRE) Like many other marketing activities within the industry, pharmaceutical speaker programs -- and the physician-industry relationships that they consist of -- are under attack, most recently by the Boston Globe. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
AtCor Medical Holdings Ltd.: New Cardiovascular Risk Factor IdentifiedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ITASCA, IL (MARKET WIRE) AtCor Medical (ASX: ACG) the developer and marketer of the SphygmoCor(R) system which measures central blood pressure and arterial stiffness noninvasively, today announced the publication of a key National Institutes of Health (NIH)-funded study(1) using SphygmoCor in the Journal of the American College of Cardiology (JACC). (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - November 2, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare ACG Source Type: news
Smith & Nephew Plc: Total Voting RightsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
London, UK (MARKET WIRE) (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 30, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare SNN Source Type: news
Plex Systems: Plex Systems CEO and President to Moderate Product Diversification Panel at MichBio Conference Nov. 3 - 4, 2009, Kalamazoo, Mich.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AUBURN HILLS, MI (MARKET WIRE) Plex Systems, Inc., provider of the No. 1 rated ERP software for manufacturers including medical device manufacturers, announced today that CEO and President Mark Symonds will be moderating a product diversification panel discussion at the MichBio Expo 2009 to be held at the Radisson Plaza Hotel in Kalamazoo, Michigan November 3 - 4, 2009. Plex Systems will also exhibit at the event. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 29, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Computers and Software Source Type: news
CNS Response: Results of Landmark Depression Efficacy Study to Be Discussed by CNS Response in a Conference Call and Web ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
COSTA MESA, CA (MARKET WIRE) CNS Response, Inc. (OTCBB: CNSO) today announced that CEO George Carpenter will be conducting a conference call and simultaneous web conference to discuss top-line study results in a 12-week trial for patients with depression treatment failure on Tuesday, November 3, at 8:00 a.m. Pacific (PST), 11:00 a.m. Eastern (EST). Joining Mr. Carpenter will be CNS Response President and CMO Daniel Hoffman, M.D., and Charles DeBattista, M.D., Stanford University School of Medicine. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 29, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare CNSO Source Type: news
Revolutions Medical Corp.: RevMed CEO Ron Wheet Details Growth Strategy in Online Audio InterviewEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHARLESTON, SC (MARKET WIRE) Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that CEO Ron Wheet has been featured in the popular AllPennyStocks.com Spotlight series, produced by TheNewsWire.ca. The thorough interview provides valuable, fresh insight into both the RevVac and MRI product lines -- straight from the Company's CEO. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 27, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Professional Services Environment RMCP Source Type: news
ALDA Pharmaceuticals Corp.: ALDA Enters Into Supplier Agreement With T&T SupermarketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) ALDA Pharmaceuticals Corp. (TSX VENTURE: APH)(OTCBB: APCSF) ("the Company" or "ALDA") announces that it has entered into a Supplier Agreement with T&T Supermarket Inc. ("T&T"). ALDA's products will be distributed through T&T's 17 stores in BC, Alberta and Ontario. Dr Terrance Owen, President & CEO states, "This agreement with T&T is an important step in achieving distribution of our products to consumers. We look forward to forging other partnerships that are equally as important as this one." (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 27, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare APH APCSF Source Type: news
MichBio: MichBio Expo & Conference Exhibitors ProfiledEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
KALAMAZOO, MI (MARKET WIRE) (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 27, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Source Type: news
Wolf Greenfield: Biotechnology Patents: Wolf Greenfield Seminar, Nov. 18, CambridgeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BOSTON, MA (MARKET WIRE) A free seminar on drafting biotechnology patents will be held by Wolf, Greenfield & Sacks, P.C., an intellectual property law firm, on November 18 in Cambridge. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 26, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Professional Services Source Type: news
Surescripts: Rhode Island's Success With E-Prescribing Leads to First-of-a-Kind System for Tracking Swine FluEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WARWICK, RI (MARKET WIRE) At a press conference featuring healthcare leaders from throughout the state, Governor Donald L. Carcieri announced that Rhode Island was launching a new system for tracking swine flu. Unprecedented in its approach, the system makes use of prescribing data provided by pharmacies throughout the state via a secure electronic link. It is enabled by the state's success with e-prescribing and the digital healthcare infrastructure available through its partnership with Surescripts, The Nation's E-Prescription Network. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 26, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Computers and Software Medical and Healthcare Source Type: news
ALDA Pharmaceuticals Corp.: ALDA Becomes Official Supplier to Richmond Olympic OvalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) ALDA Pharmaceuticals Corp. (TSX VENTURE: APH)(OTCBB: APCSF) ("the Company" or "ALDA") announces that it has entered into a multi-year agreement with the Richmond Olympic Oval Corporation ("the Oval") to be a sponsor and the exclusive supplier of hand sanitation and disinfectant products. Under the terms of the agreement, ALDA will pay an annual sponsorship fee to the Oval. In return, the Oval will provide ALDA with extensive advertising exposure in the facility and on its website and will prominently feature ALDA's products throughout the building. Dr. Terrance Owen, President & CE...
Source: Market Wire - Pharmaceuticals and Biotech - October 26, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare APH APCSF Source Type: news
Takeda Pharmaceuticals North America: New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for Nighttime Heartburn in Adults With Non-Erosive GERDEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, CA (MARKET WIRE) New data being presented at the American College of Gastroenterology (ACG) 2009 Annual Scientific Meeting in San Diego showed that treatment with KAPIDEX(TM) (dexlansoprazole) delayed release capsules over a four-week period resulted in a statistically significant greater percentage of nights without heartburn in subjects with non-erosive gastroesophageal reflux disease (GERD), compared to placebo (p < 0.001). In addition, secondary measures showed that KAPIDEX improved relief of nighttime heartburn and GERD-related sleep disturbances (p < 0.001). KAPIDEX was approved in January 2009 for the (So...
Source: Market Wire - Pharmaceuticals and Biotech - October 26, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
MarketResearch.com: New Challenges and Opportunities Face Healthcare and Information Technology MarketsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ROCKVILLE, MD (MARKET WIRE) MarketResearch.com has announced the addition of Kalorama Information's new report, "Healthcare Computer System Markets and Trends In HIT Buying (Forecasts for System, Service and Support Revenues, Areas of Interest, Major Competitor Profiles)," to their collection of Healthcare market reports. For more information, visit http://www.marketresearch.com/redirect.asp?progid=67618&productid=2303131 (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 26, 2009 Category: Pharmaceuticals Tags: Financial Services Pharmaceuticals and Biotech Medical and Healthcare Professional Services Media and Entertainment Source Type: news
Salix Pharmaceuticals: Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific MeetingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, CA (MARKET WIRE) Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announces that the 2009 American College of Gastroenterology (ACG) Annual Scientific Meeting will be the venue for 13 presentations describing the investigation of the Company's bacterial-related disease, inflammatory bowel disease and bowel cleansing product lines. ACG is being held in San Diego, CA October 23-28. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 26, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech SLXP Source Type: news
Paladin Labs Inc.: Paladin Labs Inc. Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research From Gates FoundationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MONTREAL, CANADA (MARKET WIRE) Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company announced today that its Paladin Biosciences division has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Dr. Rajan George, the Chief Technology Officer of Paladin Biosciences, titled "Dendritic cell receptor-targeted malaria vaccines". (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 23, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech PLB Source Type: news
Unilife Medical Solution: Unilife CEO Makes Open Market Purchase of $500,000 of Company SharesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LEWISBERRY, PA (MARKET WIRE) Unilife Medical Solutions Limited ("Unilife" or "the Company") (ASX: UNI) (PINKSHEETS: UNIFF) today announced that its Chief Executive Officer Alan Shortall has made open market purchases of Company shares. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 23, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare UNI UNIFF Source Type: news
Cutting Edge Information: Cutting Edge Information Investigates Pfizer-Wyeth Merger, Studies Current M&A DriversEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RESEARCH TRIANGLE PARK, NC (MARKET WIRE) Drug companies are carefully navigating the current stretch of industry consolidation as giants merge and promising small firms seek interested buyers. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 22, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
Omron Electronic Components LLC: Supporting the Market in Full Force: Omron Expands Application Oriented Sales Team to Include Transportation FocusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SCHAUMBURG, IL (MARKET WIRE) Omron Electronic Components LLC has announced the expansion of their Application Oriented Sales (AOS) team to include the Transportation industry. At its launch, in April 2009, the AOS team strategically set out to focus on the Hand Held, Video over Fiber, Automated Test Equipment (ATE), and Home Appliance markets. With months of considerable dedication to customer support and coordinated technical assistance, the team has realized a number of successes in seeing customers' designs progress from concept to completion while minimizing time to market. The proven synergy between the (Source: Marke...
Source: Market Wire - Pharmaceuticals and Biotech - October 22, 2009 Category: Pharmaceuticals Tags: Automotive Pharmaceuticals and Biotech Professional Services Electronics and Semiconductors Source Type: news
Revolutions Medical Corp.: RevMed Signs the First of Many Collaboration Agreements With Major Medical UniversitiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHARLESTON, SC (MARKET WIRE) Revolutions Medical Corporation ("RevMed" or the "Company") (OTCBB: RMCP), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it has entered into a non-disclosure agreement ("NDA") with a major South Carolina university hospital (the "Hospital"). The agreement makes possible collaboration between RevMed and the Hospital on future applications of RevMed's proprietary MRI Technology. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 21, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Computers and Software Medical and Healthcare Environment Lifestyle and Leisure RMCP Source Type: news
Unilife Medical Solution: Unilife to Exhibit at Two Major Pharmaceutical Industry EventsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LEWISBERRY, PA (MARKET WIRE) Unilife Medical Solutions Limited ("Unilife" or "the Company") (ASX: UNI) (PINKSHEETS: UNIFF) today announced it will be exhibiting at two upcoming pharmaceutical trade shows and conferences. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 21, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare UNI UNIFF Source Type: news
Trinity Biotech Plc: Trinity Biotech Announces Third Quarter 2009 Financial ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DUBLIN, IRELAND (MARKET WIRE) Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2009. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 21, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare TRIB Source Type: news
Cutting Edge Information: Cutting Edge Information Analyzes How Drug Makers Embrace Comparative Effectiveness Research (CER)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RESEARCH TRIANGLE PARK, NC (MARKET WIRE) A higher percentage of companies are using Comparative Effectiveness Research to help with pricing and reimbursement decisions, according to new research from Cutting Edge Information. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
Caleco Pharma Corp.: Product Development Advisor for Caleco Pharma Corp., Harry Fong, Phd, Conducts Exclusive Webcast Interview With the Green Baron Report; New "Stock Pick" Coverage InitiatedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BELLINGHAM, WASHINGTON (MARKET WIRE) Caleco Pharma Corp. (the "Company") (OTCBB: CAEH)(FRANKFURT: T3R)(WKN: AON9YO) (www.calecopharmacorp.com) today announced that its Advisor for Product Development, Professor Harry Fong, has conducted an exclusive new audio-taped webcast interview so that the Company's shareholders and the investment community can learn more about the Company's recently developments and plans to confirm positive tests for its product aimed at liver health. Unrestricted access to the webcast is now available on the "Webcasts" page at www.TheGreenBaron.com. This webcast is also available at (Source: Market...
Source: Market Wire - Pharmaceuticals and Biotech - October 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare CAEH T3R Source Type: news
Crucell N.V.: Crucell Rabies Monoclonal Antibody Combination: Positive Results Philippines Phase II Study Presented at RITA ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LEIDEN, NETHERLANDS (MARKET WIRE) Dutch biopharma company Crucell N.V. (Euronext, Nasdaq: CRXL) (SWISS: CRX) today announced that detailed results of the Phase II Philippines study of its rabies monoclonal antibody combination (CL 184) were presented at the XX Rabies in the Americas (RITA) Conference in Quebec, Canada. The presentation was given by Dr Beatriz P. Quiambao (MD), Chief Clinical Research Division and Head, Rabies Research Group, Research Institute for Tropical Medicine, Muntinlupa, Philippines and is available on Crucell's website www.crucell.com. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Chemicals CRXL Source Type: news
Advanced Proteome Therapeutics Corporation: Advanced Proteome Therapeutics Files Patent Application on Swift Linkage Multivalent TechnologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) In continuing efforts to advance the field of Protein Modification Technologies, Advanced Proteome Therapeutics ("APT") (TSX VENTURE: APC) has filed what it believes is a landmark patent application this month on inventions related to its Swift Linkage Multivalent Technology (SMLT). This Patent, along with previous discoveries, represents a milestone in the company's development and is a significant step toward commercialization. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech APC Source Type: news
Metatomix: Metatomix Collaborating With NATO C3 Agency to Develop a Semantic Technology Solution for Integration of Data Sources Within a Maritime ScenarioEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DEDHAM, MA (MARKET WIRE) Metatomix, Inc., a leading provider of semantic solutions to justice and public safety, financial services, manufacturing and life sciences organizations, has been awarded a contract by the NATO Consultation, Command and Control Agency (NC3A) to collaborate in the development of a data integration framework using semantic technology that allows a 360 degree view of vessels of interest within a maritime scenario. Managed by NC3A under the direction of NATO's Allied Command Transformation (ACT), this initiative, contributing to the concept development phase of Maritime Situational Awareness, (Source:...
Source: Market Wire - Pharmaceuticals and Biotech - October 20, 2009 Category: Pharmaceuticals Tags: Government Pharmaceuticals and Biotech Computers and Software Medical and Healthcare Aerospace and Defense Source Type: news
OR-Live, Inc.: REMINDER: This Week on ORLive: View High Definition Surgical Video From Sony, See a Robotic Assisted Kidney Cancer Surgery, and Preview Laparoscopic Bariatric Surgery OptionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WEST HARTFORD, CT (MARKET WIRE) ORLive, the world's leading medical and surgical broadcasting company announces the availability of new High Definition Surgical Video in partnership with Sony, will broadcast a new webcast from Wake Forest University Baptist Medical Center focusing on robotic assisted kidney cancer surgery, previews an upcoming live broadcast from Thomas Jefferson University Hospital focusing on laparoscopic bariatric surgery, and presents the latest installment of the Virtual Brain Tumor Board: (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Computers and Software Medical and Healthcare Professional Services Source Type: news
HearAtLast Holdings, Inc.: HearAtLast Pioneers New iSign Direct Marketing TechnologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MISSISSAUGA, ON (MARKET WIRE) (PINKSHEETS: HRAL) HearAtLast Holdings, Inc., a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today that it will begin a pilot with iSign Media in a new and innovative method of direct marketing. (Source: Market Wire - Pharmaceuticals and Biotech)
Source: Market Wire - Pharmaceuticals and Biotech - October 20, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Telecom Medical and Healthcare Retail HRAL Source Type: news
